- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.2: 11 residues within 4Å:- Chain A: S.17, T.18, A.21, D.113
- Chain B: N.58
- Chain G: G.56, A.57, S.58, T.71, A.72, D.73
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain G- Hydrogen bonds: A:T.18, G:G.56, G:G.56, G:T.71, G:T.71, G:D.73
NAG-NAG-BMA-MAN.4: 10 residues within 4Å:- Chain B: N.107, I.108, T.109
- Chain C: W.88, D.89, T.94
- Chain D: D.56, N.58, F.114, T.115
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:D.56, D:N.58, D:T.115
NAG-NAG-BMA-MAN.17: 8 residues within 4Å:- Chain B: K.67, T.206, E.245, N.246
- Chain E: A.31, D.49, S.51, F.90
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain B- Hydrogen bonds: E:R.52, B:K.67, E:D.49, E:S.51
- Hydrophobic interactions: B:T.206
NAG-NAG-BMA-MAN.19: 11 residues within 4Å:- Chain I: S.17, T.18, A.21, D.113
- Chain J: N.58
- Chain O: G.56, A.57, S.58, T.71, A.72, D.73
4 PLIP interactions:1 interactions with chain I, 3 interactions with chain O- Hydrogen bonds: I:T.18, O:G.56, O:G.56, O:T.71, O:T.71, O:D.73
NAG-NAG-BMA-MAN.21: 10 residues within 4Å:- Chain J: N.107, I.108, T.109
- Chain K: W.88, D.89, T.94
- Chain L: D.56, N.58, F.114, T.115
2 PLIP interactions:2 interactions with chain L- Hydrogen bonds: L:D.56, L:N.58, L:T.115
NAG-NAG-BMA-MAN.34: 8 residues within 4Å:- Chain J: K.67, T.206, E.245, N.246
- Chain M: A.31, D.49, S.51, F.90
3 PLIP interactions:1 interactions with chain M, 2 interactions with chain J- Hydrogen bonds: M:R.52, J:K.67, M:D.49, M:S.51
- Hydrophobic interactions: J:T.206
NAG-NAG-BMA-MAN.36: 11 residues within 4Å:- Chain Q: S.17, T.18, A.21, D.113
- Chain R: N.58
- Chain W: G.56, A.57, S.58, T.71, A.72, D.73
4 PLIP interactions:3 interactions with chain W, 1 interactions with chain Q- Hydrogen bonds: W:G.56, W:G.56, Q:T.18, W:T.71, W:T.71, W:D.73
NAG-NAG-BMA-MAN.38: 10 residues within 4Å:- Chain R: N.107, I.108, T.109
- Chain S: W.88, D.89, T.94
- Chain T: D.56, N.58, F.114, T.115
2 PLIP interactions:2 interactions with chain T- Hydrogen bonds: T:D.56, T:N.58, T:T.115
NAG-NAG-BMA-MAN.51: 8 residues within 4Å:- Chain R: K.67, T.206, E.245, N.246
- Chain U: A.31, D.49, S.51, F.90
3 PLIP interactions:1 interactions with chain U, 2 interactions with chain R- Hydrogen bonds: U:R.52, R:K.67, U:D.49, U:S.51
- Hydrophobic interactions: R:T.206
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.3: 6 residues within 4Å:- Chain B: N.103, D.110, M.112, K.117, R.140, K.159
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:M.112
NAG-NAG.10: 4 residues within 4Å:- Chain B: Q.263, N.265, V.302, S.303
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 3 residues within 4Å:- Chain B: N.271, I.292, V.410
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 5 residues within 4Å:- Chain B: S.357, N.361
- Ligands: NAG-NAG-BMA.12, NAG-NAG-BMA-MAN-MAN.13, NAG-NAG-BMA-MAN-MAN.13
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 4 residues within 4Å:- Chain B: P.261, V.414, N.416
- Chain H: D.75
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 6 residues within 4Å:- Chain J: N.103, D.110, M.112, K.117, R.140, K.159
1 PLIP interactions:1 interactions with chain J- Hydrogen bonds: J:M.112
NAG-NAG.27: 4 residues within 4Å:- Chain J: Q.263, N.265, V.302, S.303
No protein-ligand interaction detected (PLIP)NAG-NAG.28: 3 residues within 4Å:- Chain J: N.271, I.292, V.410
No protein-ligand interaction detected (PLIP)NAG-NAG.31: 5 residues within 4Å:- Chain J: S.357, N.361
- Ligands: NAG-NAG-BMA.29, NAG-NAG-BMA-MAN-MAN.30, NAG-NAG-BMA-MAN-MAN.30
No protein-ligand interaction detected (PLIP)NAG-NAG.33: 4 residues within 4Å:- Chain J: P.261, V.414, N.416
- Chain P: D.75
No protein-ligand interaction detected (PLIP)NAG-NAG.37: 6 residues within 4Å:- Chain R: N.103, D.110, M.112, K.117, R.140, K.159
1 PLIP interactions:1 interactions with chain R- Hydrogen bonds: R:M.112
NAG-NAG.44: 4 residues within 4Å:- Chain R: Q.263, N.265, V.302, S.303
No protein-ligand interaction detected (PLIP)NAG-NAG.45: 3 residues within 4Å:- Chain R: N.271, I.292, V.410
No protein-ligand interaction detected (PLIP)NAG-NAG.48: 5 residues within 4Å:- Chain R: S.357, N.361
- Ligands: NAG-NAG-BMA.46, NAG-NAG-BMA-MAN-MAN.47, NAG-NAG-BMA-MAN-MAN.47
No protein-ligand interaction detected (PLIP)NAG-NAG.50: 4 residues within 4Å:- Chain R: P.261, V.414, N.416
- Chain X: D.75
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.5: 5 residues within 4Å:- Chain B: V.104, T.105, N.118, Y.135, D.290
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.13: 5 residues within 4Å:- Chain B: N.355, S.357
- Ligands: NAG-NAG-BMA.12, NAG-NAG-BMA.12, NAG-NAG.14
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.22: 5 residues within 4Å:- Chain J: V.104, T.105, N.118, Y.135, D.290
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.30: 5 residues within 4Å:- Chain J: N.355, S.357
- Ligands: NAG-NAG-BMA.29, NAG-NAG-BMA.29, NAG-NAG.31
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.39: 5 residues within 4Å:- Chain R: V.104, T.105, N.118, Y.135, D.290
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.47: 5 residues within 4Å:- Chain R: N.355, S.357
- Ligands: NAG-NAG-BMA.46, NAG-NAG-BMA.46, NAG-NAG.48
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.6: 5 residues within 4Å:- Chain B: Q.100, S.120, N.122, K.131, K.133
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.23: 5 residues within 4Å:- Chain J: Q.100, S.120, N.122, K.131, K.133
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.40: 5 residues within 4Å:- Chain R: Q.100, S.120, N.122, K.131, K.133
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.7: 4 residues within 4Å:- Chain B: R.162, N.167
- Chain F: K.19
- Chain J: R.278
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:K.19, F:K.19
NAG-NAG-BMA-MAN.24: 4 residues within 4Å:- Chain J: R.162, N.167
- Chain N: K.19
- Chain R: R.278
2 PLIP interactions:2 interactions with chain N- Hydrogen bonds: N:K.19, N:K.19
NAG-NAG-BMA-MAN.41: 4 residues within 4Å:- Chain B: R.278
- Chain R: R.162, N.167
- Chain V: K.19
2 PLIP interactions:2 interactions with chain V- Hydrogen bonds: V:K.19, V:K.19
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.9: 10 residues within 4Å:- Chain B: S.179, E.181, P.182, L.231, N.232, R.274, N.346, G.348, V.414, S.415
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN.26: 10 residues within 4Å:- Chain J: S.179, E.181, P.182, L.231, N.232, R.274, N.346, G.348, V.414, S.415
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN.43: 10 residues within 4Å:- Chain R: S.179, E.181, P.182, L.231, N.232, R.274, N.346, G.348, V.414, S.415
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.15: 17 residues within 4Å:- Chain B: T.267, R.296, H.299, N.301, S.381, T.383
- Chain C: S.24, N.44, N.45, P.60, G.61, S.62
- Chain D: R.103, I.104, G.106, V.107, V.108
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain B- Hydrophobic interactions: D:V.108
- Hydrogen bonds: D:V.108, B:R.296, B:R.296
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.32: 17 residues within 4Å:- Chain J: T.267, R.296, H.299, N.301, S.381, T.383
- Chain K: S.24, N.44, N.45, P.60, G.61, S.62
- Chain L: R.103, I.104, G.106, V.107, V.108
4 PLIP interactions:2 interactions with chain L, 2 interactions with chain J- Hydrophobic interactions: L:V.108
- Hydrogen bonds: L:V.108, J:R.296, J:R.296
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.49: 17 residues within 4Å:- Chain R: T.267, R.296, H.299, N.301, S.381, T.383
- Chain S: S.24, N.44, N.45, P.60, G.61, S.62
- Chain T: R.103, I.104, G.106, V.107, V.108
4 PLIP interactions:2 interactions with chain T, 2 interactions with chain R- Hydrophobic interactions: T:V.108
- Hydrogen bonds: T:V.108, R:R.296, R:R.296
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.52: 2 residues within 4Å:- Chain A: K.122, N.126
No protein-ligand interaction detected (PLIP)NAG.53: 1 residues within 4Å:- Chain B: N.324
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:K.316, B:K.316, B:N.324
NAG.54: 2 residues within 4Å:- Chain I: K.122, N.126
No protein-ligand interaction detected (PLIP)NAG.55: 1 residues within 4Å:- Chain J: N.324
3 PLIP interactions:3 interactions with chain J- Hydrogen bonds: J:K.316, J:K.316, J:N.324
NAG.56: 2 residues within 4Å:- Chain Q: K.122, N.126
No protein-ligand interaction detected (PLIP)NAG.57: 1 residues within 4Å:- Chain R: N.324
3 PLIP interactions:3 interactions with chain R- Hydrogen bonds: R:K.316, R:K.316, R:N.324
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xu, K. et al., Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Nat. Med. (2018)
- Release Date
- 2018-05-16
- Peptides
- Glycoprotein gp41: AIQ
Glycoprotein 120: BJR
PGT122 Light Chain: CKS
PGT122 Heavy Chain: DLT
VRC03 light chain: EMU
VRC03 Heavy Chain: FNV
vFP16.02 Heavy Chain: GOW
vFP16.02 Light Chain: HPX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
cI
AQ
DB
dJ
2R
CC
nK
6S
ND
mL
5T
ME
rM
7U
RF
qN
8V
QG
hO
3W
HH
lP
4X
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xu, K. et al., Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Nat. Med. (2018)
- Release Date
- 2018-05-16
- Peptides
- Glycoprotein gp41: AIQ
Glycoprotein 120: BJR
PGT122 Light Chain: CKS
PGT122 Heavy Chain: DLT
VRC03 light chain: EMU
VRC03 Heavy Chain: FNV
vFP16.02 Heavy Chain: GOW
vFP16.02 Light Chain: HPX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
cI
AQ
DB
dJ
2R
CC
nK
6S
ND
mL
5T
ME
rM
7U
RF
qN
8V
QG
hO
3W
HH
lP
4X
L